TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 50 filers reported holding TOKAI PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $541,000 | – | 62,007 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,178,992 | $17,378,000 | 1.41% |
| Green Owl Capital Management, LLC | 86,000 | $1,268,000 | 1.14% |
| Perceptive Advisors | 485,338 | $7,154,000 | 0.60% |
| DSC Advisors, L.P. | 135,008 | $1,990,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 153,841 | $2,268,000 | 0.39% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 567,978 | $8,372,000 | 0.36% |
| Redmile Group, LLC | 215,139 | $3,171,000 | 0.34% |
| Tourbillon Capital Partners, L.P. | 517,000 | $7,621,000 | 0.21% |
| AWM Investment Company, Inc. | 100,000 | $1,474,000 | 0.20% |
| DESTRIER CAPITAL MANAGEMENT LLC | 16,800 | $248,000 | 0.07% |